Health and Safety Code § 489.051: PATIENT ELIGIBILITY
No bill in the 90th Legislature changes this section yet
Follow this section in Texas Bill Atlas: a bill filed later that changes it shows up as new.
Part of Health and Safety Code Chapter 489, with every bill that changes it.
Bills are matched to sections automatically from their text and can be missed, for example when a bill changes a whole chapter at once or renumbers sections. No bill listed here does not mean no bill changes this section.
Current law
Sec. 489.051. PATIENT ELIGIBILITY. A patient is eligible to access and use an investigational drug, biological product, or device under this chapter if:
(1) the patient has a terminal illness, attested to by the patient's treating physician; and
(2) the patient's physician:
(A) in consultation with the patient, has considered all other treatment options currently approved by the United States Food and Drug Administration and determined that those treatment options are unavailable or unlikely to prolong the patient's life; and
(B) has recommended or prescribed in writing that the patient use a specific class of investigational drug, biological product, or device.
Added by Acts 2015, 84th Leg., R.S., Ch. 502 (H.B. 21), Sec. 2, eff. June 16, 2015.
Links
- This chapter as it stands now, Markdown copy of the Texas Legislative Council's statute files
- Official text on statutes.capitol.texas.gov
- RSS feed of actions on these bills
Texas Bill Atlas is an independent research tool, not an official state website.